SCM
Silverarc Capital Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $926K | Buy |
3,128,421
+39,916
| +1% | +$11.8K | 0.17% | 47 |
|
|
2025
Q1 | $1.06M | Buy |
+3,088,505
| New | +$1.06M | 0.22% | 59 |
|
|
2024
Q4 | – | Sell |
-1,585,786
| Closed | -$3M | – | 70 |
|
|
2024
Q3 | $3M | Sell |
1,585,786
-914,799
| -37% | -$1.73M | 0.67% | 42 |
|
|
2024
Q2 | $5.03M | Sell |
2,500,585
-468,213
| -16% | -$941K | 1.19% | 27 |
|
|
2024
Q1 | $13.3M | Sell |
2,968,798
-3,451,338
| -54% | -$15.5M | 3.69% | 5 |
|
|
2023
Q4 | $14.9M | Buy |
6,420,136
+1,420,136
| +28% | +$3.29M | 4.43% | 2 |
|
|
2023
Q3 | $6.35M | Buy |
5,000,000
+4,000,000
| +400% | +$5.08M | 1.93% | 17 |
|
|
2023
Q2 | $3.29M | Buy |
1,000,000
+459,941
| +85% | +$1.51M | 1.02% | 31 |
|
|
2023
Q1 | $2.22M | Sell |
540,059
-600,123
| -53% | -$2.47M | 0.92% | 39 |
|
|
2022
Q4 | $6.68M | Buy |
1,140,182
+146,109
| +15% | +$856K | 1.91% | 14 |
|
|
2022
Q3 | $6.72M | Buy |
994,073
+144,073
| +17% | +$974K | 2.27% | 10 |
|
|
2022
Q2 | $3.93M | Buy |
+850,000
| New | +$3.93M | 1.21% | 18 |
|
|
2021
Q3 | – | Sell |
-125,123
| Closed | -$1.7K | – | 93 |
|
|
2021
Q2 | $1.7K | Buy |
125,123
+100,123
| +400% | +$1.36K | 0.76% | 47 |
|
|
2021
Q1 | $405K | Buy |
25,000
+14,237
| +132% | +$231K | 0.22% | 76 |
|
|
2020
Q4 | $286K | Buy |
+10,763
| New | +$286K | 0.17% | 75 |
|